CDC/IDSA COVID-19 Clinician Call: Emerging SARS-CoV-2 Variants: Updates & Implications

To Download a copy of the presentation click here.

To Download a copy of the Q&A Responses click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.

Moderator:

Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

Updated Guidelines on the Management of Adults with COVID-19 in the ICU

Greg Martin, MD, MSc, FCCM
President of the Society of Critical Care Medicine
Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
Emory University School of Medicine

Emerging SARS-CoV-2 Variants: Updates & Implications

Angela L. Rasmussen, PhD
Affiliate
Georgetown University
Center for Global Health Science and Security
Adam Lauring, MD, PhD
Associate Professor
Infectious Diseases; Microbiology & Immunology
University of Michigan Medical School
Gregory Armstrong, MD
Director, Office of Advanced Molecular Detection
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention